Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Study Purpose

This phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma. Radiation therapy uses high energy photons to kill tumor and shrink tumors. Chemotherapy drugs, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Temozolomide, may not work as well for the treatment of tumors that have the unmethylated MGMT. Immunotherapy with monoclonal antibodies called immune checkpoint inhibitors, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is possible that immune checkpoint inhibitors may work better at time of first diagnosis as opposed to when tumor comes back. Giving radiation therapy with ipilimumab and nivolumab may lengthen the time without brain tumor returning or growing and may extend patients' life compared to usual treatment with radiation therapy and temozolomide.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - PRIOR TO STEP 1 REGISTRATION: - No known IDH mutation.
(If tested before step 1 registration, patients known to have IDH mutation in the tumor on local or other testing are ineligible and should not be registered)
  • - Availability of formalin-fixed paraffin-embedded (FFPE) tumor tissue block and hematoxylin & eosin (H&E) stained slide to be sent for central pathology review for confirmation of histology and MGMT promoter methylation status.
Note that tissue for central pathology review and central MGMT assessment must be received by the New York University (NYU) Center for Biospecimen Research and Development (CBRD) on or before postoperative calendar day 23. If tissue cannot be received by postoperative calendar day 23, then patients may NOT enroll on this trial as central pathology review will not be complete in time for the patient to start treatment no later than 6 weeks following surgery. Results of central pathology review and central MGMT analysis will generally be conveyed to NRG Oncology within 10 business days of receipt of tissue. Note: In the event of an additional tumor resection(s), tissue must be received within 23 days of the most recent resection and the latest resection must have been performed within 30 days after the initial resection. Surgical resection (partial or complete) is required; a limited biopsy is not allowed because it will not provide sufficient tissue for MGMT analysis.
  • - Note: The central pathology review and central MGMT results determine eligibility.
Therefore, patients may be offered the opportunity to consent REGARDLESS of local pathology and MGMT results, and consent can occur BEFORE local pathology interpretation is finalized and BEFORE local MGMT testing is conducted.
  • - Contrast-enhanced brain MRI within 3 days after surgery.
  • - MRI with Axial T2 weighted FLAIR {preferred} or T2 turbo spin echo (TSE)/fast spin echo (FSE) and 3-dimensional (3D) contrast-enhanced T1 sequences are required.
  • - 3D pre contrast-enhanced T1 sequences are strongly suggested.
  • - Women of childbearing potential (WOCBP) and men who are sexually active with WOCBP must be willing to use an adequate method of contraception hormonal or barrier method of birth control; or abstinence during and after treatment.
  • - The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
  • - PRIOR TO STEP 2 REGISTRATION: - Histopathologically proven diagnosis of glioblastoma (or gliosarcoma as a subtype of glioblastoma) confirmed by central pathology review.
  • - Note: diagnoses of "Molecular glioblastoma" per the Consortium to Inform Molecular and Practical Approaches to Central Nervous System (CNS) Tumor Taxonomy (c-IMPACT-NOW) criteria or "CNS grade 4" per the World Health Organization (WHO) 2021 criteria are NOT relevant.
  • - MGMT promoter without methylation confirmed by central pathology review.
Note: Patients with tissue that is insufficient or inadequate for analysis, fails MGMT testing, or has indeterminate or methylated MGMT promoter are excluded.
  • - Note: central pathology review and central MGMT results determine eligibility; local pathology or MGMT results cannot be used for eligibility/randomization.
  • - Note: patients with methylated MGMT may be considered for enrollment on NRG-BN011.
  • - IDH mutation testing by at least one method (such as immunohistochemistry for IDH1 R132H) must be performed as part of standard of care and no mutation must be found (i.
e IDH wildtype). (If a mutation is identified then the patient will be ineligible and must be registered as ineligible at step 2.)
  • - Note: this test is not being performed in real time as part of central review and will not be provided to sites from a centrally performed test.
  • - History/physical examination within 28 days prior to step 2 registration.
  • - Karnofsky Performance Status (KPS) >= 70 within 28 days prior to step 2 registration.
  • - Neurologic function assessment within 28 days prior to step 2 registration.
  • - Age >= 18 years.
  • - Hemoglobin >= 10 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable) (within 7 days prior to step 2 registration) - Leukocytes >= 2,000/mm^3 (within 7 days prior to step 2 registration) - Absolute neutrophil count >= 1,500/mm^3 (within 7 days prior to step 2 registration) - Platelets >= 100,000/mm^3 (within 7 days prior to step 2 registration) - Total bilirubin =< 1.5 x institutional/lab upper limit of normal (ULN) (within 7 days prior to step 2 registration) - Aspartate transaminase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< 2.5 x ULN (within 7 days prior to step 2 registration) - Alanine transferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (within 7 days prior to step 2 registration) - Serum creatinine =< 1.5 x ULN OR creatinine clearance (CrCl) >= 50 mL/min (if using the Cockcroft-Gault formula) (within 7 days prior to step 2 registration) - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.
  • - For women of childbearing potential (WOCBP), negative serum or urine pregnancy test within 7 days prior to step 2 registration.
Note that it may need to be repeated if not also within 3 days prior to treatment start.
  • - Women of childbearing potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal.
Menopause is defined clinically as 12 months of amenorrhea in a woman over 45 in the absence of other biological or physiological causes.

Exclusion Criteria:

  • - Prior therapy for tumor except for resection.
For example, prior chemotherapy, immunotherapy, or targeted therapy for GBM or lower grade glioma is disallowed (including but not limited to temozolomide, lomustine, bevacizumab, any viral therapy, ipilimumab or other CTLA-4 antibody, PD-1 antibody, CD-137 agonist, CD40 antibody, PDL-1 or 2 antibody, vaccine therapy, polio or similar viral injection as treatment for the tumor, and/or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways) as is prior Laser interstitial thermal therapy (LITT), Gliadel wafer, radiotherapy, radiosurgery, gamma knife, cyber knife, vaccine or other immunotherapy, brachytherapy, or convection enhanced delivery;
  • - Note that 5-aminolevulinic acid (ALA)-mediated fluorescent guided resection (FGR) photodynamic therapy (PDT) or fluorescein administered prior to/during surgery to aid resection is not exclusionary and is not considered a chemotherapy or intracerebral agent.
  • - Current or planned treatment with any other investigational agents for the study cancer.
  • - Definitive clinical or radiologic evidence of metastatic disease outside the brain.
  • - Prior invasive malignancy (except non-melanomatous skin cancer, cervical cancer in situ and melanoma in situ) unless disease free for a minimum of 2 years.
  • - Prior radiotherapy to the head or neck that would result in overlap of radiation therapy fields.
  • - Pregnancy and nursing females due to the potential teratogenic effects and potential risk for adverse events in nursing infants.
  • - History of severe hypersensitivity reaction to any monoclonal antibody.
  • - History of allergic reactions attributed to compounds of similar chemical or biologic composition to ipilimumab, nivolumab, or temozolomide.
  • - On any dose of any systemically administered (oral, rectal, intravenous) corticosteroid within 3 days prior to step 2 registration.
Inhaled, topical, and ocular corticosteroids are allowed without limitation but must be recorded. Note that treatment with systemically administered corticosteroid after initiating study treatment is allowed as needed.
  • - Patients with known immune impairment who may be unable to respond to anti-CTLA 4 antibody.
  • - History of interstitial lung disease including but not limited to sarcoidosis or pneumonitis.
  • - Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, defined as New York Heart Association functional classification III/IV (Note: Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association functional classification), unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
  • - Known history of testing positive for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS) - Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids, are excluded, as are patients on active immunosuppressive therapy.
These include but are not limited to: patients with a history of immune-related neurologic disease, CNS or motor neuropathy, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as autoimmune vasculitis [e.g., Wegener's Granulomatosis]), systemic lupus erythematosus (SLE), connective tissue diseases (e.g., systemic progressive sclerosis), scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome, Hashimoto's thyroiditis, autoimmune hepatitis are excluded because of the risk of recurrence or exacerbation of disease.
  • - Exceptions: patients with a history of the following conditions are not excluded, unless receiving active immunosuppressive therapy: - Vitiligo.
  • - Type I diabetes.
  • - Rheumatoid arthritis and other arthropathies.
  • - Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA) - Anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible.
  • - Patients who have evidence of active or acute diverticulitis, intra-abdominal abscess, gastrointestinal (GI) obstruction and abdominal carcinomatosis which are known risk factors for bowel perforation are also excluded.
- Current or planned therapy with warfarin

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04396860
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 2/Phase 3
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

National Cancer Institute (NCI)
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Andrew B Lassman
Principal Investigator Affiliation NRG Oncology
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

NIH, Other
Overall Status Active, not recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Gliosarcoma, MGMT-Unmethylated Glioblastoma
Additional Details

PRIMARY OBJECTIVES:

  • I. To determine if adding ipilimumab and nivolumab to radiotherapy significantly prolongs progression-free survival (PFS) versus adding temozolomide to radiotherapy in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.
(Phase II)
  • II. To determine if adding ipilimumab and nivolumab to radiotherapy significantly prolongs overall survival (OS) versus adding temozolomide to radiotherapy in patients with newly diagnosed GBM without MGMT promoter methylation.
(Phase III) SECONDARY OBJECTIVES:
  • I. To determine if adding ipilimumab and nivolumab to radiotherapy significantly prolongs PFS versus adding temozolomide to radiotherapy in patients with newly diagnosed GBM without MGMT promoter methylation for the phase III part of the study.
  • II. To determine if adding ipilimumab and nivolumab to radiotherapy significantly increases the 2-year OS rate versus adding temozolomide to radiotherapy in patients with newly diagnosed GBM without MGMT promoter methylation.
  • III. To evaluate the safety of adding ipilimumab and nivolumab to radiotherapy via comparative frequency between arms of specific adverse events of interest and frequency summaries for all adverse event types.
  • IV. To evaluate the effect of adding ipilimumab and nivolumab to radiotherapy versus adding temozolomide to radiotherapy on patient reported outcomes (PROs), as measured by the MD Anderson Symptom Inventory - Brain Tumor (MDASI-BT) in patients with newly diagnosed GBM without MGMT promoter methylation.
  • V. To evaluate the effect of adding ipilimumab and nivolumab to radiotherapy versus adding temozolomide to radiotherapy on selected Patient Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE) items in patients with newly diagnosed GBM without MGMT promoter methylation.
  • VI. To evaluate the impact of adding ipilimumab and nivolumab to radiotherapy versus adding temozolomide to radiotherapy on neurocognitive function (NCF) in patients with newly diagnosed GBM without MGMT promoter methylation.
EXPLORATORY OBJECTIVES:
  • I. To explore biomarkers in pre-treatment archival tumor tissue that may predict efficacy of ipilimumab and nivolumab as measured by OS, PFS, and 2-year OS rate, such as but not limited to: Ia.
PDL1 expression; Ib. Mutational burden.
  • II. To explore (in the two treatment separately) whether the MGMT protein expression correlates with clinical outcomes including OS, PFS, and 2-year OS rate.
  • III. To evaluate if MGMT protein expression may be predictive of differential treatment effects between the two treatment arms.
OUTLINE: Patients are randomized to 1 of 2 arms. ARM 1: Patients undergo radiation therapy for 5 days per week (Monday-Friday) for a total of 30 fractions over 6 weeks and simultaneously receive temozolomide orally (PO) daily for 6 weeks. After radiation, patients may wear the Optune device at the discretion of the patient and their treating physician. Beginning 1 month after radiation therapy, patients receive temozolomide on days 1-5. Treatment repeats every 28 days for up to 12 cycles at the discretion of the treating investigator in the absence of disease progression or unacceptable toxicity. Patients also undergo contrast-enhanced brain magnetic resonance imaging (MRI) throughout the trial. ARM 2: Patients undergo radiation therapy for 5 days per week (Monday-Friday) for a total of 30 fractions over 6 weeks. Starting on the first day of radiation, patients also receive ipilimumab intravenously (IV) over 90 minutes once every 4 weeks (Q4W) for 4 doses and nivolumab IV over 30 minutes every 2 weeks until disease progression. Patients also undergo contrast-enhanced brain MRI throughout the trial. After completion of study treatment, patients are followed up every 3 months for year 1, then every 4 months for year 2, and then every 6 months thereafter.

Arms & Interventions

Arms

Active Comparator: Arm I (radiation therapy, temozolomide)

Patients undergo radiation therapy for 5 days per week (Monday-Friday) for a total of 30 fractions over 6 weeks and simultaneously receive temozolomide PO daily for 6 weeks. After radiation, patients may wear the Optune device at the discretion of the patient and their treating physician. Beginning 1 month after radiation therapy, patients receive temozolomide on days 1-5. Treatment repeats every 28 days for up to 12 cycles at the discretion of the treating investigator in the absence of disease progression or unacceptable toxicity. Patients also undergo contrast-enhanced brain MRI throughout the trial.

Experimental: Arm II (radiation therapy, ipilimumab, nivolumab)

Patients undergo radiation therapy for 5 days per week (Monday-Friday) for a total of 30 fractions over 6 weeks. Starting on the first day of radiation, patients also receive ipilimumab IV over 90 minutes Q4W for 4 doses and nivolumab IV over 30 minutes every 2 weeks until disease progression. Patients also undergo contrast-enhanced brain MRI throughout the trial.

Interventions

Procedure: - Contrast-enhanced Magnetic Resonance Imaging

Undergo contrast-enhanced brain MRI

Biological: - Ipilimumab

Given IV

Biological: - Nivolumab

Given IV

Device: - NovoTTF-100A Device

Wear Optune device

Other: - Quality-of-Life Assessment

Ancillary studies

Other: - Questionnaire Administration

Ancillary studies

Radiation: - Radiation Therapy

Undergo radiation therapy

Drug: - Temozolomide

Given PO

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Birmingham, Alabama

Status

Address

University of Alabama at Birmingham Cancer Center

Birmingham, Alabama, 35233

Little Rock, Arkansas

Status

Address

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205

Kaiser Permanente-Anaheim, Anaheim, California

Status

Address

Kaiser Permanente-Anaheim

Anaheim, California, 92806

Sutter Auburn Faith Hospital, Auburn, California

Status

Address

Sutter Auburn Faith Hospital

Auburn, California, 95602

Auburn, California

Status

Address

Sutter Cancer Centers Radiation Oncology Services-Auburn

Auburn, California, 95603

John Muir Medical Center-Concord Campus, Concord, California

Status

Address

John Muir Medical Center-Concord Campus

Concord, California, 94520

UC San Diego Moores Cancer Center, La Jolla, California

Status

Address

UC San Diego Moores Cancer Center

La Jolla, California, 92093

Loma Linda University Medical Center, Loma Linda, California

Status

Address

Loma Linda University Medical Center

Loma Linda, California, 92354

Los Angeles, California

Status

Address

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, 90027

Cedars Sinai Medical Center, Los Angeles, California

Status

Address

Cedars Sinai Medical Center

Los Angeles, California, 90048

Kaiser Permanente-Ontario, Ontario, California

Status

Address

Kaiser Permanente-Ontario

Ontario, California, 91761

Orange, California

Status

Address

UC Irvine Health/Chao Family Comprehensive Cancer Center

Orange, California, 92868

Roseville, California

Status

Address

Sutter Cancer Centers Radiation Oncology Services-Roseville

Roseville, California, 95661

Sutter Roseville Medical Center, Roseville, California

Status

Address

Sutter Roseville Medical Center

Roseville, California, 95661

Sutter Medical Center Sacramento, Sacramento, California

Status

Address

Sutter Medical Center Sacramento

Sacramento, California, 95816

Sacramento, California

Status

Address

University of California Davis Comprehensive Cancer Center

Sacramento, California, 95817

Torrance, California

Status

Address

Torrance Memorial Physician Network - Cancer Care

Torrance, California, 90505

Torrance Memorial Medical Center, Torrance, California

Status

Address

Torrance Memorial Medical Center

Torrance, California, 90509

John Muir Medical Center-Walnut Creek, Walnut Creek, California

Status

Address

John Muir Medical Center-Walnut Creek

Walnut Creek, California, 94598

Penrose-Saint Francis Healthcare, Colorado Springs, Colorado

Status

Address

Penrose-Saint Francis Healthcare

Colorado Springs, Colorado, 80907

Porter Adventist Hospital, Denver, Colorado

Status

Address

Porter Adventist Hospital

Denver, Colorado, 80210

Littleton Adventist Hospital, Littleton, Colorado

Status

Address

Littleton Adventist Hospital

Littleton, Colorado, 80122

Parker Adventist Hospital, Parker, Colorado

Status

Address

Parker Adventist Hospital

Parker, Colorado, 80138

Hartford Hospital, Hartford, Connecticut

Status

Address

Hartford Hospital

Hartford, Connecticut, 06102

The Hospital of Central Connecticut, New Britain, Connecticut

Status

Address

The Hospital of Central Connecticut

New Britain, Connecticut, 06050

Beebe South Coastal Health Campus, Frankford, Delaware

Status

Address

Beebe South Coastal Health Campus

Frankford, Delaware, 19945

Beebe Medical Center, Lewes, Delaware

Status

Address

Beebe Medical Center

Lewes, Delaware, 19958

Newark, Delaware

Status

Address

Delaware Clinical and Laboratory Physicians PA

Newark, Delaware, 19713

Helen F Graham Cancer Center, Newark, Delaware

Status

Address

Helen F Graham Cancer Center

Newark, Delaware, 19713

Newark, Delaware

Status

Address

Medical Oncology Hematology Consultants PA

Newark, Delaware, 19713

Newark, Delaware

Status

Address

Christiana Care Health System-Christiana Hospital

Newark, Delaware, 19718

Beebe Health Campus, Rehoboth Beach, Delaware

Status

Address

Beebe Health Campus

Rehoboth Beach, Delaware, 19971

Baptist MD Anderson Cancer Center, Jacksonville, Florida

Status

Address

Baptist MD Anderson Cancer Center

Jacksonville, Florida, 32207

AdventHealth Orlando, Orlando, Florida

Status

Address

AdventHealth Orlando

Orlando, Florida, 32803

Augusta University Medical Center, Augusta, Georgia

Status

Address

Augusta University Medical Center

Augusta, Georgia, 30912

Savannah, Georgia

Status

Address

Memorial Health University Medical Center

Savannah, Georgia, 31404

Savannah, Georgia

Status

Address

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Savannah, Georgia, 31405

Lewis Hall Singletary Oncology Center, Thomasville, Georgia

Status

Address

Lewis Hall Singletary Oncology Center

Thomasville, Georgia, 31792

Hawaii Cancer Care - Westridge, 'Aiea, Hawaii

Status

Address

Hawaii Cancer Care - Westridge

'Aiea, Hawaii, 96701

Pali Momi Medical Center, 'Aiea, Hawaii

Status

Address

Pali Momi Medical Center

'Aiea, Hawaii, 96701

Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii

Status

Address

Queen's Cancer Center - Pearlridge

'Aiea, Hawaii, 96701

The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii

Status

Address

The Cancer Center of Hawaii-Pali Momi

'Aiea, Hawaii, 96701

Honolulu, Hawaii

Status

Address

Hawaii Cancer Care Inc - Waterfront Plaza

Honolulu, Hawaii, 96813

Island Urology, Honolulu, Hawaii

Status

Address

Island Urology

Honolulu, Hawaii, 96813

Queen's Cancer Cenrer - POB I, Honolulu, Hawaii

Status

Address

Queen's Cancer Cenrer - POB I

Honolulu, Hawaii, 96813

Queen's Medical Center, Honolulu, Hawaii

Status

Address

Queen's Medical Center

Honolulu, Hawaii, 96813

Straub Clinic and Hospital, Honolulu, Hawaii

Status

Address

Straub Clinic and Hospital

Honolulu, Hawaii, 96813

University of Hawaii Cancer Center, Honolulu, Hawaii

Status

Address

University of Hawaii Cancer Center

Honolulu, Hawaii, 96813

Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii

Status

Address

Hawaii Cancer Care Inc-Liliha

Honolulu, Hawaii, 96817

Queen's Cancer Center - Kuakini, Honolulu, Hawaii

Status

Address

Queen's Cancer Center - Kuakini

Honolulu, Hawaii, 96817

The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii

Status

Address

The Cancer Center of Hawaii-Liliha

Honolulu, Hawaii, 96817

Honolulu, Hawaii

Status

Address

Kapiolani Medical Center for Women and Children

Honolulu, Hawaii, 96826

Castle Medical Center, Kailua, Hawaii

Status

Address

Castle Medical Center

Kailua, Hawaii, 96734

Lihue, Hawaii

Status

Address

Wilcox Memorial Hospital and Kauai Medical Clinic

Lihue, Hawaii, 96766

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Status

Address

Saint Luke's Cancer Institute - Boise

Boise, Idaho, 83712

Caldwell, Idaho

Status

Address

Saint Alphonsus Cancer Care Center-Caldwell

Caldwell, Idaho, 83605

Fruitland, Idaho

Status

Address

Saint Luke's Cancer Institute - Fruitland

Fruitland, Idaho, 83619

Saint Luke's Cancer Institute - Meridian, Meridian, Idaho

Status

Address

Saint Luke's Cancer Institute - Meridian

Meridian, Idaho, 83642

Saint Luke's Cancer Institute - Nampa, Nampa, Idaho

Status

Address

Saint Luke's Cancer Institute - Nampa

Nampa, Idaho, 83686

Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho

Status

Address

Saint Alphonsus Cancer Care Center-Nampa

Nampa, Idaho, 83687

Twin Falls, Idaho

Status

Address

Saint Luke's Cancer Institute - Twin Falls

Twin Falls, Idaho, 83301

Illinois CancerCare-Bloomington, Bloomington, Illinois

Status

Address

Illinois CancerCare-Bloomington

Bloomington, Illinois, 61704

Illinois CancerCare-Canton, Canton, Illinois

Status

Address

Illinois CancerCare-Canton

Canton, Illinois, 61520

Illinois CancerCare-Carthage, Carthage, Illinois

Status

Address

Illinois CancerCare-Carthage

Carthage, Illinois, 62321

Centralia Oncology Clinic, Centralia, Illinois

Status

Address

Centralia Oncology Clinic

Centralia, Illinois, 62801

Northwestern University, Chicago, Illinois

Status

Address

Northwestern University

Chicago, Illinois, 60611

University of Illinois, Chicago, Illinois

Status

Address

University of Illinois

Chicago, Illinois, 60612

Carle at The Riverfront, Danville, Illinois

Status

Address

Carle at The Riverfront

Danville, Illinois, 61832

Decatur, Illinois

Status

Address

Cancer Care Specialists of Illinois - Decatur

Decatur, Illinois, 62526

Decatur Memorial Hospital, Decatur, Illinois

Status

Address

Decatur Memorial Hospital

Decatur, Illinois, 62526

DeKalb, Illinois

Status

Address

Northwestern Medicine Cancer Center Kishwaukee

DeKalb, Illinois, 60115

Carle Physician Group-Effingham, Effingham, Illinois

Status

Address

Carle Physician Group-Effingham

Effingham, Illinois, 62401

Crossroads Cancer Center, Effingham, Illinois

Status

Address

Crossroads Cancer Center

Effingham, Illinois, 62401

Elmhurst Memorial Hospital, Elmhurst, Illinois

Status

Address

Elmhurst Memorial Hospital

Elmhurst, Illinois, 60126

Illinois CancerCare-Eureka, Eureka, Illinois

Status

Address

Illinois CancerCare-Eureka

Eureka, Illinois, 61530

Evanston, Illinois

Status

Address

NorthShore University HealthSystem-Evanston Hospital

Evanston, Illinois, 60201

Illinois CancerCare-Galesburg, Galesburg, Illinois

Status

Address

Illinois CancerCare-Galesburg

Galesburg, Illinois, 61401

Western Illinois Cancer Treatment Center, Galesburg, Illinois

Status

Address

Western Illinois Cancer Treatment Center

Galesburg, Illinois, 61401

Geneva, Illinois

Status

Address

Northwestern Medicine Cancer Center Delnor

Geneva, Illinois, 60134

Glenview, Illinois

Status

Address

NorthShore University HealthSystem-Glenbrook Hospital

Glenview, Illinois, 60026

Highland Park, Illinois

Status

Address

NorthShore University HealthSystem-Highland Park Hospital

Highland Park, Illinois, 60035

Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois

Status

Address

Illinois CancerCare-Kewanee Clinic

Kewanee, Illinois, 61443

Illinois CancerCare-Macomb, Macomb, Illinois

Status

Address

Illinois CancerCare-Macomb

Macomb, Illinois, 61455

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Status

Address

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, 61938

Edward Hospital/Cancer Center, Naperville, Illinois

Status

Address

Edward Hospital/Cancer Center

Naperville, Illinois, 60540

Cancer Care Center of O'Fallon, O'Fallon, Illinois

Status

Address

Cancer Care Center of O'Fallon

O'Fallon, Illinois, 62269

Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois

Status

Address

Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, 61350

Advocate Lutheran General Hospital, Park Ridge, Illinois

Status

Address

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068

Illinois CancerCare-Pekin, Pekin, Illinois

Status

Address

Illinois CancerCare-Pekin

Pekin, Illinois, 61554

Illinois CancerCare-Peoria, Peoria, Illinois

Status

Address

Illinois CancerCare-Peoria

Peoria, Illinois, 61615

Methodist Medical Center of Illinois, Peoria, Illinois

Status

Address

Methodist Medical Center of Illinois

Peoria, Illinois, 61636

OSF Saint Francis Medical Center, Peoria, Illinois

Status

Address

OSF Saint Francis Medical Center

Peoria, Illinois, 61637

Illinois CancerCare-Peru, Peru, Illinois

Status

Address

Illinois CancerCare-Peru

Peru, Illinois, 61354

Illinois CancerCare-Princeton, Princeton, Illinois

Status

Address

Illinois CancerCare-Princeton

Princeton, Illinois, 61356

Rockford, Illinois

Status

Address

SwedishAmerican Regional Cancer Center/ACT

Rockford, Illinois, 61114

Springfield, Illinois

Status

Address

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Springfield Clinic, Springfield, Illinois

Status

Address

Springfield Clinic

Springfield, Illinois, 62702

Memorial Medical Center, Springfield, Illinois

Status

Address

Memorial Medical Center

Springfield, Illinois, 62781

Carle Cancer Center, Urbana, Illinois

Status

Address

Carle Cancer Center

Urbana, Illinois, 61801

The Carle Foundation Hospital, Urbana, Illinois

Status

Address

The Carle Foundation Hospital

Urbana, Illinois, 61801

Warrenville, Illinois

Status

Address

Northwestern Medicine Cancer Center Warrenville

Warrenville, Illinois, 60555

Illinois CancerCare - Washington, Washington, Illinois

Status

Address

Illinois CancerCare - Washington

Washington, Illinois, 61571

Indianapolis, Indiana

Status

Address

Indiana University/Melvin and Bren Simon Cancer Center

Indianapolis, Indiana, 46202

IU Health Methodist Hospital, Indianapolis, Indiana

Status

Address

IU Health Methodist Hospital

Indianapolis, Indiana, 46202

Mary Greeley Medical Center, Ames, Iowa

Status

Address

Mary Greeley Medical Center

Ames, Iowa, 50010

McFarland Clinic - Ames, Ames, Iowa

Status

Address

McFarland Clinic - Ames

Ames, Iowa, 50010

Clive, Iowa

Status

Address

Medical Oncology and Hematology Associates-West Des Moines

Clive, Iowa, 50325

Mercy Cancer Center-West Lakes, Clive, Iowa

Status

Address

Mercy Cancer Center-West Lakes

Clive, Iowa, 50325

Heartland Oncology and Hematology LLP, Council Bluffs, Iowa

Status

Address

Heartland Oncology and Hematology LLP

Council Bluffs, Iowa, 51503

Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa

Status

Address

Methodist Jennie Edmundson Hospital

Council Bluffs, Iowa, 51503

Greater Regional Medical Center, Creston, Iowa

Status

Address

Greater Regional Medical Center

Creston, Iowa, 50801

Iowa Methodist Medical Center, Des Moines, Iowa

Status

Address

Iowa Methodist Medical Center

Des Moines, Iowa, 50309

Des Moines, Iowa

Status

Address

Medical Oncology and Hematology Associates-Des Moines

Des Moines, Iowa, 50309

Broadlawns Medical Center, Des Moines, Iowa

Status

Address

Broadlawns Medical Center

Des Moines, Iowa, 50314

Mercy Medical Center - Des Moines, Des Moines, Iowa

Status

Address

Mercy Medical Center - Des Moines

Des Moines, Iowa, 50314

Mission Cancer and Blood - Laurel, Des Moines, Iowa

Status

Address

Mission Cancer and Blood - Laurel

Des Moines, Iowa, 50314

Iowa City, Iowa

Status

Address

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, Iowa, 52242

Mercy Medical Center-West Lakes, West Des Moines, Iowa

Status

Address

Mercy Medical Center-West Lakes

West Des Moines, Iowa, 50266

Lexington, Kentucky

Status

Address

University of Kentucky/Markey Cancer Center

Lexington, Kentucky, 40536

Tulane University School of Medicine, New Orleans, Louisiana

Status

Address

Tulane University School of Medicine

New Orleans, Louisiana, 70112

Ochsner Medical Center Jefferson, New Orleans, Louisiana

Status

Address

Ochsner Medical Center Jefferson

New Orleans, Louisiana, 70121

Eastern Maine Medical Center, Bangor, Maine

Status

Address

Eastern Maine Medical Center

Bangor, Maine, 04401

Bath, Maine

Status

Address

MaineHealth Coastal Cancer Treatment Center

Bath, Maine, 04530

Waldo County General Hospital, Belfast, Maine

Status

Address

Waldo County General Hospital

Belfast, Maine, 04915

Lafayette Family Cancer Center-EMMC, Brewer, Maine

Status

Address

Lafayette Family Cancer Center-EMMC

Brewer, Maine, 04412

Maine Medical Center-Bramhall Campus, Portland, Maine

Status

Address

Maine Medical Center-Bramhall Campus

Portland, Maine, 04102

Penobscot Bay Medical Center, Rockport, Maine

Status

Address

Penobscot Bay Medical Center

Rockport, Maine, 04856

Sanford, Maine

Status

Address

MaineHealth Cancer Care Center of York County

Sanford, Maine, 04073

Maine Medical Center- Scarborough Campus, Scarborough, Maine

Status

Address

Maine Medical Center- Scarborough Campus

Scarborough, Maine, 04074

Maine Medical Partners Neurology, Scarborough, Maine

Status

Address

Maine Medical Partners Neurology

Scarborough, Maine, 04074

Maine Medical Partners - South Portland, South Portland, Maine

Status

Address

Maine Medical Partners - South Portland

South Portland, Maine, 04106

Baltimore, Maryland

Status

Address

University of Maryland/Greenebaum Cancer Center

Baltimore, Maryland, 21201

UM Upper Chesapeake Medical Center, Bel Air, Maryland

Status

Address

UM Upper Chesapeake Medical Center

Bel Air, Maryland, 21014

Columbia, Maryland

Status

Address

Central Maryland Radiation Oncology in Howard County

Columbia, Maryland, 21044

Glen Burnie, Maryland

Status

Address

UM Baltimore Washington Medical Center/Tate Cancer Center

Glen Burnie, Maryland, 21061

Saint Joseph Mercy Hospital, Ann Arbor, Michigan

Status

Address

Saint Joseph Mercy Hospital

Ann Arbor, Michigan, 48106

Saint Joseph Mercy Brighton, Brighton, Michigan

Status

Address

Saint Joseph Mercy Brighton

Brighton, Michigan, 48114

Brighton, Michigan

Status

Address

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Saint Joseph Mercy Canton, Canton, Michigan

Status

Address

Saint Joseph Mercy Canton

Canton, Michigan, 48188

Canton, Michigan

Status

Address

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Saint Joseph Mercy Chelsea, Chelsea, Michigan

Status

Address

Saint Joseph Mercy Chelsea

Chelsea, Michigan, 48118

Chelsea, Michigan

Status

Address

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Beaumont Hospital - Dearborn, Dearborn, Michigan

Status

Address

Beaumont Hospital - Dearborn

Dearborn, Michigan, 48124

Ascension Saint John Hospital, Detroit, Michigan

Status

Address

Ascension Saint John Hospital

Detroit, Michigan, 48236

Genesys Hurley Cancer Institute, Flint, Michigan

Status

Address

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Hurley Medical Center, Flint, Michigan

Status

Address

Hurley Medical Center

Flint, Michigan, 48503

Spectrum Health at Butterworth Campus, Grand Rapids, Michigan

Status

Address

Spectrum Health at Butterworth Campus

Grand Rapids, Michigan, 49503

Bronson Methodist Hospital, Kalamazoo, Michigan

Status

Address

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

West Michigan Cancer Center, Kalamazoo, Michigan

Status

Address

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Borgess Medical Center, Kalamazoo, Michigan

Status

Address

Borgess Medical Center

Kalamazoo, Michigan, 49048

Livonia, Michigan

Status

Address

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

21st Century Oncology-Pontiac, Pontiac, Michigan

Status

Address

21st Century Oncology-Pontiac

Pontiac, Michigan, 48341

William Beaumont Hospital-Royal Oak, Royal Oak, Michigan

Status

Address

William Beaumont Hospital-Royal Oak

Royal Oak, Michigan, 48073

Ascension Saint Mary's Hospital, Saginaw, Michigan

Status

Address

Ascension Saint Mary's Hospital

Saginaw, Michigan, 48601

Saginaw, Michigan

Status

Address

Oncology Hematology Associates of Saginaw Valley PC

Saginaw, Michigan, 48604

Ascension Saint Joseph Hospital, Tawas City, Michigan

Status

Address

Ascension Saint Joseph Hospital

Tawas City, Michigan, 48764

William Beaumont Hospital - Troy, Troy, Michigan

Status

Address

William Beaumont Hospital - Troy

Troy, Michigan, 48085

Saint John Macomb-Oakland Hospital, Warren, Michigan

Status

Address

Saint John Macomb-Oakland Hospital

Warren, Michigan, 48093

West Branch, Michigan

Status

Address

Saint Mary's Oncology/Hematology Associates of West Branch

West Branch, Michigan, 48661

University of Michigan Health - West, Wyoming, Michigan

Status

Address

University of Michigan Health - West

Wyoming, Michigan, 49519

Ypsilanti, Michigan

Status

Address

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Sanford Joe Lueken Cancer Center, Bemidji, Minnesota

Status

Address

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, 56601

Fairview Ridges Hospital, Burnsville, Minnesota

Status

Address

Fairview Ridges Hospital

Burnsville, Minnesota, 55337

Minnesota Oncology - Burnsville, Burnsville, Minnesota

Status

Address

Minnesota Oncology - Burnsville

Burnsville, Minnesota, 55337

Mercy Hospital, Coon Rapids, Minnesota

Status

Address

Mercy Hospital

Coon Rapids, Minnesota, 55433

Fairview Southdale Hospital, Edina, Minnesota

Status

Address

Fairview Southdale Hospital

Edina, Minnesota, 55435

Unity Hospital, Fridley, Minnesota

Status

Address

Unity Hospital

Fridley, Minnesota, 55432

Maple Grove, Minnesota

Status

Address

Fairview Clinics and Surgery Center Maple Grove

Maple Grove, Minnesota, 55369

Maplewood, Minnesota

Status

Address

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, 55109

Hennepin County Medical Center, Minneapolis, Minnesota

Status

Address

Hennepin County Medical Center

Minneapolis, Minnesota, 55415

Health Partners Inc, Minneapolis, Minnesota

Status

Address

Health Partners Inc

Minneapolis, Minnesota, 55454

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

Status

Address

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Regions Hospital, Saint Paul, Minnesota

Status

Address

Regions Hospital

Saint Paul, Minnesota, 55101

United Hospital, Saint Paul, Minnesota

Status

Address

United Hospital

Saint Paul, Minnesota, 55102

Lakeview Hospital, Stillwater, Minnesota

Status

Address

Lakeview Hospital

Stillwater, Minnesota, 55082

University of Mississippi Medical Center, Jackson, Mississippi

Status

Address

University of Mississippi Medical Center

Jackson, Mississippi, 39216

Southhaven, Mississippi

Status

Address

Baptist Memorial Hospital and Cancer Center-Desoto

Southhaven, Mississippi, 38671

Saint Francis Medical Center, Cape Girardeau, Missouri

Status

Address

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Billings Clinic Cancer Center, Billings, Montana

Status

Address

Billings Clinic Cancer Center

Billings, Montana, 59101

Bozeman Deaconess Hospital, Bozeman, Montana

Status

Address

Bozeman Deaconess Hospital

Bozeman, Montana, 59715

Butte, Montana

Status

Address

Saint James Community Hospital and Cancer Treatment Center

Butte, Montana, 59701

Great Falls, Montana

Status

Address

Benefis Healthcare- Sletten Cancer Institute

Great Falls, Montana, 59405

Kalispell Regional Medical Center, Kalispell, Montana

Status

Address

Kalispell Regional Medical Center

Kalispell, Montana, 59901

Nebraska Medicine-Bellevue, Bellevue, Nebraska

Status

Address

Nebraska Medicine-Bellevue

Bellevue, Nebraska, 68123

Cancer Partners of Nebraska - Pine Lake, Lincoln, Nebraska

Status

Address

Cancer Partners of Nebraska - Pine Lake

Lincoln, Nebraska, 68516

Lincoln, Nebraska

Status

Address

Southeast Nebraska Cancer Center - 68th Street Place

Lincoln, Nebraska, 68516

Nebraska Methodist Hospital, Omaha, Nebraska

Status

Address

Nebraska Methodist Hospital

Omaha, Nebraska, 68114

Nebraska Medicine-Village Pointe, Omaha, Nebraska

Status

Address

Nebraska Medicine-Village Pointe

Omaha, Nebraska, 68118

University of Nebraska Medical Center, Omaha, Nebraska

Status

Address

University of Nebraska Medical Center

Omaha, Nebraska, 68198

Lebanon, New Hampshire

Status

Address

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center

Lebanon, New Hampshire, 03756

Hackensack University Medical Center, Hackensack, New Jersey

Status

Address

Hackensack University Medical Center

Hackensack, New Jersey, 07601

Saint Barnabas Medical Center, Livingston, New Jersey

Status

Address

Saint Barnabas Medical Center

Livingston, New Jersey, 07039

Morristown Medical Center, Morristown, New Jersey

Status

Address

Morristown Medical Center

Morristown, New Jersey, 07960

Jersey Shore Medical Center, Neptune, New Jersey

Status

Address

Jersey Shore Medical Center

Neptune, New Jersey, 07753

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Status

Address

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, 08903

Capital Health Medical Center-Hopewell, Pennington, New Jersey

Status

Address

Capital Health Medical Center-Hopewell

Pennington, New Jersey, 08534

Overlook Hospital, Summit, New Jersey

Status

Address

Overlook Hospital

Summit, New Jersey, 07902

New York, New York

Status

Address

Laura and Isaac Perlmutter Cancer Center at NYU Langone

New York, New York, 10016

New York, New York

Status

Address

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, New York, 10032

NYP/Weill Cornell Medical Center, New York, New York

Status

Address

NYP/Weill Cornell Medical Center

New York, New York, 10065

University of Rochester, Rochester, New York

Status

Address

University of Rochester

Rochester, New York, 14642

Syracuse, New York

Status

Address

State University of New York Upstate Medical University

Syracuse, New York, 13210

Good Samaritan University Hospital, West Islip, New York

Status

Address

Good Samaritan University Hospital

West Islip, New York, 11795

Charlotte, North Carolina

Status

Address

Carolinas Medical Center/Levine Cancer Institute

Charlotte, North Carolina, 28203

Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina

Status

Address

Atrium Health Pineville/LCI-Pineville

Charlotte, North Carolina, 28210

Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina

Status

Address

Atrium Health Cabarrus/LCI-Concord

Concord, North Carolina, 28025

Sanford Bismarck Medical Center, Bismarck, North Dakota

Status

Address

Sanford Bismarck Medical Center

Bismarck, North Dakota, 58501

Sanford Broadway Medical Center, Fargo, North Dakota

Status

Address

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Sanford Roger Maris Cancer Center, Fargo, North Dakota

Status

Address

Sanford Roger Maris Cancer Center

Fargo, North Dakota, 58122

Summa Health System - Akron Campus, Akron, Ohio

Status

Address

Summa Health System - Akron Campus

Akron, Ohio, 44304

Case Western Reserve University, Cleveland, Ohio

Status

Address

Case Western Reserve University

Cleveland, Ohio, 44106

Cleveland Clinic Foundation, Cleveland, Ohio

Status

Address

Cleveland Clinic Foundation

Cleveland, Ohio, 44195

Riverside Methodist Hospital, Columbus, Ohio

Status

Address

Riverside Methodist Hospital

Columbus, Ohio, 43214

Dublin Methodist Hospital, Dublin, Ohio

Status

Address

Dublin Methodist Hospital

Dublin, Ohio, 43016

Lawton, Oklahoma

Status

Address

Cancer Centers of Southwest Oklahoma Research

Lawton, Oklahoma, 73505

Oklahoma City, Oklahoma

Status

Address

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Clackamas Radiation Oncology Center, Clackamas, Oregon

Status

Address

Clackamas Radiation Oncology Center

Clackamas, Oregon, 97015

Clackamas, Oregon

Status

Address

Providence Cancer Institute Clackamas Clinic

Clackamas, Oregon, 97015

Legacy Mount Hood Medical Center, Gresham, Oregon

Status

Address

Legacy Mount Hood Medical Center

Gresham, Oregon, 97030

Providence Newberg Medical Center, Newberg, Oregon

Status

Address

Providence Newberg Medical Center

Newberg, Oregon, 97132

Portland, Oregon

Status

Address

Legacy Good Samaritan Hospital and Medical Center

Portland, Oregon, 97210

Providence Portland Medical Center, Portland, Oregon

Status

Address

Providence Portland Medical Center

Portland, Oregon, 97213

Providence Saint Vincent Medical Center, Portland, Oregon

Status

Address

Providence Saint Vincent Medical Center

Portland, Oregon, 97225

Kaiser Permanente Northwest, Portland, Oregon

Status

Address

Kaiser Permanente Northwest

Portland, Oregon, 97227

Legacy Meridian Park Hospital, Tualatin, Oregon

Status

Address

Legacy Meridian Park Hospital

Tualatin, Oregon, 97062

Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania

Status

Address

Lehigh Valley Hospital-Cedar Crest

Allentown, Pennsylvania, 18103

Broomall, Pennsylvania

Status

Address

Crozer-Keystone Regional Cancer Center at Broomall

Broomall, Pennsylvania, 19008

Chadds Ford, Pennsylvania

Status

Address

Christiana Care Health System-Concord Health Center

Chadds Ford, Pennsylvania, 19317

Lancaster, Pennsylvania

Status

Address

Lancaster General Ann B Barshinger Cancer Institute

Lancaster, Pennsylvania, 17601

Lancaster General Hospital, Lancaster, Pennsylvania

Status

Address

Lancaster General Hospital

Lancaster, Pennsylvania, 17602

Forbes Hospital, Monroeville, Pennsylvania

Status

Address

Forbes Hospital

Monroeville, Pennsylvania, 15146

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Status

Address

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107

Allegheny General Hospital, Pittsburgh, Pennsylvania

Status

Address

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212

Pittsburgh, Pennsylvania

Status

Address

University of Pittsburgh Cancer Institute (UPCI)

Pittsburgh, Pennsylvania, 15232

UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania

Status

Address

UPMC-Shadyside Hospital

Pittsburgh, Pennsylvania, 15232

Reading Hospital, West Reading, Pennsylvania

Status

Address

Reading Hospital

West Reading, Pennsylvania, 19611

Wexford Health and Wellness Pavilion, Wexford, Pennsylvania

Status

Address

Wexford Health and Wellness Pavilion

Wexford, Pennsylvania, 15090

Rock Hill Radiation Therapy Center, Rock Hill, South Carolina

Status

Address

Rock Hill Radiation Therapy Center

Rock Hill, South Carolina, 29730

Avera Cancer Institute at Pierre, Pierre, South Dakota

Status

Address

Avera Cancer Institute at Pierre

Pierre, South Dakota, 57501

Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota

Status

Address

Sanford Cancer Center Oncology Clinic

Sioux Falls, South Dakota, 57104

Avera Cancer Institute, Sioux Falls, South Dakota

Status

Address

Avera Cancer Institute

Sioux Falls, South Dakota, 57105

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

Status

Address

Sanford USD Medical Center - Sioux Falls

Sioux Falls, South Dakota, 57117-5134

Collierville, Tennessee

Status

Address

Baptist Memorial Hospital and Cancer Center-Collierville

Collierville, Tennessee, 38017

Memphis, Tennessee

Status

Address

Baptist Memorial Hospital and Cancer Center-Memphis

Memphis, Tennessee, 38120

Memorial Hermann Texas Medical Center, Houston, Texas

Status

Address

Memorial Hermann Texas Medical Center

Houston, Texas, 77030

San Antonio, Texas

Status

Address

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229

American Fork, Utah

Status

Address

American Fork Hospital / Huntsman Intermountain Cancer Center

American Fork, Utah, 84003

Sandra L Maxwell Cancer Center, Cedar City, Utah

Status

Address

Sandra L Maxwell Cancer Center

Cedar City, Utah, 84720

Logan Regional Hospital, Logan, Utah

Status

Address

Logan Regional Hospital

Logan, Utah, 84321

Intermountain Medical Center, Murray, Utah

Status

Address

Intermountain Medical Center

Murray, Utah, 84107

McKay-Dee Hospital Center, Ogden, Utah

Status

Address

McKay-Dee Hospital Center

Ogden, Utah, 84403

Utah Valley Regional Medical Center, Provo, Utah

Status

Address

Utah Valley Regional Medical Center

Provo, Utah, 84604

Riverton Hospital, Riverton, Utah

Status

Address

Riverton Hospital

Riverton, Utah, 84065

Saint George Regional Medical Center, Saint George, Utah

Status

Address

Saint George Regional Medical Center

Saint George, Utah, 84770

Salt Lake City, Utah

Status

Address

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, 84112

LDS Hospital, Salt Lake City, Utah

Status

Address

LDS Hospital

Salt Lake City, Utah, 84143

Berlin, Vermont

Status

Address

Central Vermont Medical Center/National Life Cancer Treatment

Berlin, Vermont, 05602

University of Vermont Medical Center, Burlington, Vermont

Status

Address

University of Vermont Medical Center

Burlington, Vermont, 05401

Burlington, Vermont

Status

Address

University of Vermont and State Agricultural College

Burlington, Vermont, 05405

Inova Schar Cancer Institute, Fairfax, Virginia

Status

Address

Inova Schar Cancer Institute

Fairfax, Virginia, 22031

Richmond, Virginia

Status

Address

Virginia Commonwealth University/Massey Cancer Center

Richmond, Virginia, 23298

VCU Community Memorial Health Center, South Hill, Virginia

Status

Address

VCU Community Memorial Health Center

South Hill, Virginia, 23970

Virginia Mason Medical Center, Seattle, Washington

Status

Address

Virginia Mason Medical Center

Seattle, Washington, 98101

Vancouver, Washington

Status

Address

Legacy Cancer Institute Medical Oncology and Day Treatment

Vancouver, Washington, 98684

Legacy Salmon Creek Hospital, Vancouver, Washington

Status

Address

Legacy Salmon Creek Hospital

Vancouver, Washington, 98686

Wheeling, West Virginia

Status

Address

Wheeling Hospital/Schiffler Cancer Center

Wheeling, West Virginia, 26003

Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin

Status

Address

Aurora Cancer Care-Southern Lakes VLCC

Burlington, Wisconsin, 53105

Germantown, Wisconsin

Status

Address

Aurora Health Care Germantown Health Center

Germantown, Wisconsin, 53022

Aurora Cancer Care-Grafton, Grafton, Wisconsin

Status

Address

Aurora Cancer Care-Grafton

Grafton, Wisconsin, 53024

Aurora BayCare Medical Center, Green Bay, Wisconsin

Status

Address

Aurora BayCare Medical Center

Green Bay, Wisconsin, 54311

UW Cancer Center Johnson Creek, Johnson Creek, Wisconsin

Status

Address

UW Cancer Center Johnson Creek

Johnson Creek, Wisconsin, 53038

Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin

Status

Address

Aurora Cancer Care-Kenosha South

Kenosha, Wisconsin, 53142

Madison, Wisconsin

Status

Address

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, 53792

Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin

Status

Address

Aurora Bay Area Medical Group-Marinette

Marinette, Wisconsin, 54143

Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin

Status

Address

Aurora Cancer Care-Milwaukee

Milwaukee, Wisconsin, 53209

Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin

Status

Address

Aurora Saint Luke's Medical Center

Milwaukee, Wisconsin, 53215

Aurora Sinai Medical Center, Milwaukee, Wisconsin

Status

Address

Aurora Sinai Medical Center

Milwaukee, Wisconsin, 53233

Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin

Status

Address

Marshfield Clinic-Minocqua Center

Minocqua, Wisconsin, 54548

Cancer Center of Western Wisconsin, New Richmond, Wisconsin

Status

Address

Cancer Center of Western Wisconsin

New Richmond, Wisconsin, 54017

Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin

Status

Address

Vince Lombardi Cancer Clinic - Oshkosh

Oshkosh, Wisconsin, 54904

Aurora Cancer Care-Racine, Racine, Wisconsin

Status

Address

Aurora Cancer Care-Racine

Racine, Wisconsin, 53406

Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin

Status

Address

Vince Lombardi Cancer Clinic-Sheboygan

Sheboygan, Wisconsin, 53081

Aurora Medical Center in Summit, Summit, Wisconsin

Status

Address

Aurora Medical Center in Summit

Summit, Wisconsin, 53066

Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin

Status

Address

Vince Lombardi Cancer Clinic-Two Rivers

Two Rivers, Wisconsin, 54241

Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin

Status

Address

Aurora Cancer Care-Milwaukee West

Wauwatosa, Wisconsin, 53226

Aurora West Allis Medical Center, West Allis, Wisconsin

Status

Address

Aurora West Allis Medical Center

West Allis, Wisconsin, 53227

Stay Informed & Connected